Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Over the last 12 months, insiders at Trupanion, Inc. have bought $499,663 and sold $2.43M worth of Trupanion, Inc. stock.
On average, over the past 5 years, insiders at Trupanion, Inc. have bought $1.14M and sold $24.64M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RAWLINGS DARRYL (Chief Executive Officer) — $499,663.
The last purchase of 20,700 shares for transaction amount of $499,663 was made by RAWLINGS DARRYL (Chief Executive Officer) on 2024‑05‑07.
2024-11-29 | Sale | Chief Financial Officer | 9,867 0.0232% | $53.08 | $523,789 | +0.86% | ||
2024-11-26 | Sale | Chief Financial Officer | 622 0.0014% | $52.61 | $32,723 | -1.29% | ||
2024-11-25 | Sale | SVP, Channel Growth | 900 0.0021% | $54.55 | $49,095 | +0.47% | ||
2024-11-22 | Sale | SVP, Channel Growth | 3,100 0.0075% | $54.85 | $170,038 | +0.09% | ||
2024-11-21 | Sale | EVP, North Am & Vet Strategy | 11,916 0.028% | $53.00 | $631,548 | +1.85% | ||
2024-11-20 | Sale | CEO | 5,000 0.0119% | $52.00 | $260,007 | +3.44% | ||
2024-11-06 | Sale | director | 2,000 0.005% | $52.67 | $105,347 | +6.47% | ||
2024-11-04 | Sale | General Manager | 2,000 0.0049% | $52.72 | $105,449 | +6.81% | ||
2024-08-28 | Sale | CEO | 7,500 0.0178% | $46.48 | $348,600 | +8.98% | ||
2024-08-26 | Sale | Chief Financial Officer | 624 0.0014% | $46.54 | $29,041 | +4.01% | ||
2024-08-16 | Sale | Chief Financial Officer | 640 0.0017% | $43.12 | $27,597 | +0.49% | ||
2024-05-30 | Sale | EVP, North Am & Vet Strategy | 1,000 0.0023% | $29.35 | $29,350 | +50.15% | ||
2024-05-30 | Sale | General Manager | 1,200 0.0029% | $30.04 | $36,054 | +50.15% | ||
2024-05-07 | Sale | SVP, Channel Growth | 3,125 0.0084% | $25.34 | $79,201 | +69.24% | ||
2024-05-07 | Chief Executive Officer | 20,700 0.0531% | $24.14 | $499,663 | +69.24% | |||
2023-11-30 | Sale | EVP, North Am & Vet Strategy | 10,170 0.025% | $26.11 | $265,518 | +13.77% | ||
2023-11-30 | Sale | General Manager | 1,213 0.003% | $26.27 | $31,866 | +13.77% | ||
2023-08-30 | Sale | director | 8,688 0.0209% | $29.99 | $260,522 | -7.20% | ||
2023-05-08 | Sale | Chief Executive Officer | 4,000 0.0096% | $25.30 | $101,188 | +5.36% | ||
2023-04-19 | Sale | Chief Executive Officer | 4,000 0.0097% | $35.48 | $141,920 | -23.74% |
RAWLINGS DARRYL | Chief Executive Officer | 614842 1.452% | $50.73 | 1 | 170 | |
Ferracone Robin A | director | 51056 0.1206% | $50.73 | 8 | 2 | +21.69% |
NOVOTNY GLENN W | director | 18974 0.0448% | $50.73 | 2 | 2 | <0.0001% |
DAVIDSON JACQUELINE L | director | 1000 0.0024% | $50.73 | 1 | 0 | +18.48% |
Wolff Andrew D. | Chief Financial Officer | 779 0.0018% | $50.73 | 2 | 0 | <0.0001% |
BlackRock | $160.29M | 13.82 | 5.81M | -2.32% | -$3.81M | <0.01 | |
Capital World Investors | $111M | 9.57 | 4.02M | 0% | +$0 | 0.02 | |
The Vanguard Group | $101.43M | 8.74 | 3.67M | +0.89% | +$896,910.84 | <0.01 | |
Aflac | $100.4M | 8.65 | 3.64M | 0% | +$0 | 98.34 | |
Flossbach von Storch | $79.52M | 6.85 | 2.88M | 0% | +$0 | 0.35 |